Clinical Trials Browser

Castrate Sensitive Prostate Cancer

Prostatic Neoplasms

Neoplasm Metastasis, Prostatic Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Prostatic Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Biochemically Recurrent Prostate Cancer

Hypertension, Kidney Diseases, Prostatic Neoplasms, Primary Dysautonomias

Prostatic Neoplasms, Castration-Resistant

Neoplasm Metastasis, Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Adenocarcinoma of the Prostate

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Metastatic Hormone Sensitive Prostate Cancer

Prostatic Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body

Prostatic Neoplasms

Breast Neoplasms

Prostatic Neoplasms

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

Metastatic Castration Resistant Prostate Cancer

Prostatic Neoplasms, Castration-Resistant

Prostatic Neoplasms

Prostatic Neoplasms, Castration-Resistant

Clinical Trials

Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer

Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer

TRAP

Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer

Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer

KEYNOTE-991

Radium-223 in Combination With Enzalutamide

Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer

PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.

ARAMON

ARCH

A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

PROSPER

CheckMate 9KD

FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)

A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan

A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)

Testosterone Therapy in Castration Resistant Prostate Cancer

ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer

Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy

An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants

ARCHES

ARROW

KEYNOTE-991

Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer

Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer

A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely

Study to Evaluate CCS1477 in Advanced Tumours

TRITON3

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer

BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)